The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Concerning Autism Spectrum Assertions

Legal Proceedings
The Texas Attorney General, who supports former President Trump campaigning for the United States Senate, alleged the drug companies of hiding the risks of acetaminophen

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the firms withheld safety concerns that the pain reliever created to children's neurological development.

The court filing arrives a month after Former President Trump advocated an unproven link between consuming acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

Paxton is suing Johnson & Johnson, which previously sold the drug, the exclusive pain medication suggested for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he stated they "deceived the public by profiting off of suffering and marketing drugs without regard for the dangers."

Kenvue says there is lacking scientific proof tying Tylenol to autism.

"These companies misled for generations, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, said.

The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the potential impact that could have on the welfare of women and children in America."

On its website, Kenvue also mentioned it had "continuously evaluated the applicable studies and there is lacking reliable evidence that indicates a established connection between using acetaminophen and autism."

Organizations acting on behalf of physicians and health professionals concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in Tylenol - is among limited choices for pregnant women to manage discomfort and fever, which can present serious health risks if not addressed.

"In over twenty years of investigation on the use of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of paracetamol in any period of pregnancy results in neurodevelopmental disorders in young ones," the organization commented.

This legal action references current declarations from the previous government in asserting the drug is allegedly unsafe.

In recent weeks, Trump generated worry from public health officials when he advised women during pregnancy to "struggle intensely" not to consume acetaminophen when sick.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the usage of Tylenol, while also stating that "a direct connection" between the medication and autism in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had promised in April to conduct "comprehensive study program" that would determine the source of autism spectrum disorder in a matter of months.

But authorities warned that finding a single cause of autism - considered by experts to be the result of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that influences how people experience and relate to the world, and is diagnosed using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is campaigning for US Senate - claims Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the evidence" around paracetamol and autism.

The lawsuit aims to force the firms "eliminate any promotional materials" that claims acetaminophen is secure for expectant mothers.

The court case parallels the concerns of a group of parents of young ones with autism spectrum disorder and ADHD who filed suit against the makers of acetaminophen in recently.

Judicial authorities threw out the lawsuit, declaring investigations from the family's specialists was lacking definitive proof.

Deborah Woods
Deborah Woods

Blockchain enthusiast and finance writer with over a decade of experience in crypto investments and mobile tech.